NCT05316831View on ClinicalTrials.gov

Immune Response After Pneumococcal Vaccination in Patient With Chronic Lymphocytic Leukemia

PHASE4CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

June 30, 2021

Study Completion Date

October 1, 2022

Conditions
CLLVaccine Response
Interventions
BIOLOGICAL

PCV13

Pneumococcal polysaccharides conjugated to CRM197 carrier protein

BIOLOGICAL

PPSV23

Pneumococcal polysaccharides

Trial Locations (1)

Unknown

Magdalena Kättström, Örebro

All Listed Sponsors
lead

Region Örebro County

OTHER

NCT05316831 - Immune Response After Pneumococcal Vaccination in Patient With Chronic Lymphocytic Leukemia | Biotech Hunter | Biotech Hunter